In the past week, ARDX stock has gone up by 13.20%, with a monthly gain of 3.07% and a quarterly surge of 11.63%. The volatility ratio for the week is 6.17%, and the volatility levels for the last 30 days are 6.77% for Ardelyx Inc The simple moving average for the last 20 days is 7.10% for ARDX’s stock, with a simple moving average of 4.12% for the last 200 days.

Is It Worth Investing in Ardelyx Inc (NASDAQ: ARDX) Right Now?

compared to its average ratio and a 36-month beta value of 0.99. Analysts have mixed views on the stock, with 8 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The average price point forecasted by analysts for Ardelyx Inc (ARDX) is $9.64, which is $5.61 above the current market price. The public float for ARDX is 222.68M, and currently, short sellers hold a 16.38% ratio of that float. The average trading volume of ARDX on November 17, 2023 was 6.80M shares.

ARDX) stock’s latest price update

Ardelyx Inc (NASDAQ: ARDX)’s stock price has gone rise by 4.13 in comparison to its previous close of 3.87, however, the company has experienced a 13.20% increase in its stock price over the last five trading days. The Motley Fool reported 2023-10-31 that Ardelyx delivered a surprise profit thanks to strong sales of Ibsrela, its first FDA-approved product. The company has also commenced the launch of Xphozah, which only just received FDA approval two weeks ago, with product expected in channel early next month.

Analysts’ Opinion of ARDX

Many brokerage firms have already submitted their reports for ARDX stocks, with H.C. Wainwright repeating the rating for ARDX by listing it as a “Buy.” The predicted price for ARDX in the upcoming period, according to H.C. Wainwright is $9 based on the research report published on September 07, 2023 of the current year 2023.

ARDX Trading at 2.39% from the 50-Day Moving Average

After a stumble in the market that brought ARDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.37% of loss for the given period.

Volatility was left at 6.77%, however, over the last 30 days, the volatility rate increased by 6.17%, as shares surge +10.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.23% lower at present.

During the last 5 trading sessions, ARDX rose by +13.20%, which changed the moving average for the period of 200-days by +33.89% in comparison to the 20-day moving average, which settled at $3.78. In addition, Ardelyx Inc saw 41.40% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ARDX starting from Rosenbaum David P., who sale 1,644 shares at the price of $4.00 back on Oct 10. After this action, Rosenbaum David P. now owns 365,378 shares of Ardelyx Inc, valued at $6,576 using the latest closing price.

Rosenbaum David P., the Chief Development Officer of Ardelyx Inc, sale 2,897 shares at $4.55 during a trade that took place back on Sep 08, which means that Rosenbaum David P. is holding 367,022 shares at $13,181 based on the most recent closing price.

Stock Fundamentals for ARDX

Current profitability levels for the company are sitting at:

The net margin for Ardelyx Inc stands at -128.85. The total capital return value is set at -46.51, while invested capital returns managed to touch -64.68. Equity return is now at value -20.60, with -12.24 for asset returns.

Based on Ardelyx Inc (ARDX), the company’s capital structure generated 48.52 points at debt to equity in total, while total debt to capital is 32.67. Total debt to assets is 25.10, with long-term debt to equity ratio resting at 17.40. Finally, the long-term debt to capital ratio is 11.72.

When we switch over and look at the enterprise to sales, we see a ratio of 6.12, with the company’s debt to enterprise value settled at 0.13. The receivables turnover for the company is 12.67 and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.34.


To put it simply, Ardelyx Inc (ARDX) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.